Inhibitory effects of diallyl disulfide on the production of inflammatory mediators and cytokines in lipopolysaccharide-activated BV2 microglia |
| |
Authors: | Park Hye Young Kim Nam Deuk Kim Gi-Young Hwang Hye Jin Kim Byung-Woo Kim Wun Jae Choi Yung Hyun |
| |
Affiliation: | a Department of Biochemistry, Dongeui University College of Oriental Medicine, Busan 614-714, Republic of Koreab Department of Pharmacy, Pusan National University, Busan 609-735, Republic of Koreac Department of Marine Life Sciences, Jeju National University, Jeju 690-756, Republic of Koread Anti-Aging Research Center & Blue-Bio Industry RIC, Dongeui University, Busan 614-714, Republic of Koreae Department of Food and Nutrition, College of Human Ecology, Dongeui University, Busan 614-714, Republic of Koreaf Department of Life Science and Biotechnology, College of Natural Science, Dongeui University, Busan 614-714, Republic of Koreag Department of Biomaterial Control, Graduate School, Dongeui University, Busan 614-714, Republic of Koreah Department of Urology, College of Medicine, Chungbuk National University, Cheongju, Chungbuk 361-763, Republic of Korea |
| |
Abstract: | Diallyl disulfide (DADS), a main organosulfur component responsible for the diverse biological effects of garlic, displays a wide variety of internal biological activities. However, the cellular and molecular mechanisms underlying DADS' anti-inflammatory activity remain poorly understood. In this study, therefore, the anti-inflammatory effects of DADS were studied to investigate its potential therapeutic effects in lipopolysaccharide (LPS)-stimulated BV2 microglia. We found that pretreatment with DADS prior to treatment with LPS significantly inhibited excessive production of nitric oxide (NO) and prostaglandin E2 (PGE2) in a dose-dependent manner. The inhibition was associated with down-regulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression. DADS also attenuated the production of pro-inflammatory cytokines and chemokines, including interleukin-1β (IL-1β), tumor necrosis factor (TNF)-α, and monocyte chemoattractant protein-1 (MCP-1) by suppressing the expression of mRNAs for these proteins. The mechanism underlying this protective effect might be related to the inhibition of nuclear factor-kappaB, Akt and mitogen-activated protein kinase signaling pathway activation in LPS-stimulated microglial cells. These findings indicated that DADS is potentially a novel therapeutic candidate for the treatment of various neurodegenerative diseases. |
| |
Keywords: | DADS Inflammation NF-κB Akt MAPK |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|